Someone said yes after you disclosed herpes, HIV or another STI. Here's how to keep dating them as a whole person, talk about sex and protection, and build a real relationship.
In the PURPOSE 5 trial, 85.6% of people starting twice-yearly lenacapavir stayed on schedule for a year, versus 46.3% on daily PrEP pills. Here is what the study found, what it did not test, and what it means for dating.
Final week-104 data from the AMP trials show the VRC01 antibody kept blocking highly sensitive HIV strains, but resistant breakthrough infections rose after infusions ended. Here is what that means, and what it does not, for dating and prevention.
On PrEP and DoxyPEP and still got an STI? What each tool covers, what neither prevents (herpes, HPV, mpox, crabs), how often to test, and how condoms and vaccines fit.
Ohio Health Modernization Movement is holding its first Advocacy Day at the Statehouse on Nov. 17 to modernize six HIV criminal laws. Prosecutions have hit hundreds of people living with HIV—often regardless of transmission risk. Here's why disclosure laws still shape dating.
Tested positive for herpes while in a relationship? Learn what the diagnosis can and can't tell you, what to say, how to answer "Did you cheat?", partner testing and how couples manage herpes together.
A federal judge struck down a CMS rule that would have required people with HIV and other conditions to prove their illness limits their ability to work to stay exempt from Medicaid work requirements. What changed, what didn't, and why it matters for staying undetectable.
Tested negative for herpes 4 to 8 weeks after an exposure? What CDC and USPSTF guidance says about the antibody window period, the 12-week retest, why IgM isn't recommended, and when testing without symptoms makes sense.
The FDA tentatively approved the first generic version of lenacapavir, the twice-yearly HIV prevention shot, at $40 a year for 120 lower-income countries. Why it matters, why it can't be sold in the U.S. and what it means for mixed-status dating.
